FIGURE

Fig. 6.

ID

ZDB-FIG-220205-50

Publication

Dal et al., 2021 - The zebrafish embryo as an in vivo model for screening nanoparticle-formulated lipophilic anti-tuberculosis compounds

Other Figures

All Figure Page

Back to All Figure Page

Fig. 6.

Evaluation of the in vivo efficacy of PM-formulated nNF derivatives in the zebrafish TB model. Zebrafish embryos were infected with Mm-dsRed and treated with different doses of the PM-formulated nNF derivates C7, C11, C12 or PM-formulated RIF by intravenous injection. (A) Representative images of Mm-infected embryos treated with different doses of PM-C7 at 4 dpt. Scale bar: 500 μm. (B) Quantification of bacterial burden by FPC at 4 dpt in embryos treated with the indicated doses of the PM-formulated compounds or RIF. FPC values of individual embryos were normalized to the untreated control (ctrl) group and results are presented as mean±s.d. Results are pooled from at least three independent experiments. The mean values of each group are displayed above the columns. na, not applicable. **P<0.01, ***P<0.001 (non-parametric Kruskal–Wallis H test followed by post-hoc analysis using Dunn's multiple comparisons test).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Dis. Model. Mech.